Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders

By sjmartinez • January 24, 2023

Lazarus HM, Pitts K, Wang T, Lee E, Buchbinder E, Dougan M, Armstrong DG, Paine R 3rd, Ragsdale CE, Boyd T, Rock EP, Gale RP. Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders. Front Immunol. 2023 Jan 5;13:1069444. doi: 10.3389/fimmu.2022.1069444. PMID: 36685591; PMCID: PMC9850113.

Tags: autoimmune pulmonary alveolar proteinosis (aPAP), covid-19, granulocyte-macrophage colony-stimulating factor, immune checkpoint inhibitors (ICI), Immunomodulation, mononuclear phagocyte, Publications, Pulmonary, Critical Care & Sleep Medicine, sargramostim, wound healing

The Cardiovascular Care of the Pediatric Athlete

Dean PN, Brothers JA, Burns K, Edelson JB, Etheridge S, Phelan DM, Shafer K, Snyder C, Molossi S, Danielian A, Friedman EM, Hsu J, Husaini[...]

A prospective, multicenter, randomized controlled trial evaluating anticoagulation alone vs anticoagulation plus computer assisted vacuum thrombectomy for the treatment of intermediate-high-risk acute pulmonary embolism: Rationale and design of the STORM-PE study

Rosovsky RP, Konstantinides SV, Moriarty JM, Dohad SY, Weinberg I, Parikh SA, Channick R, Lookstein RA. A prospective, multicenter, randomized controlled trial evaluating anticoagulation alone[...]

Reply to Currow et al. and to Akgün

Heinzerling A, Harrison R, Flattery J, Fazio JC, Gandhi S, Cummings KJ. Reply to Currow et al.and to Akgün. Am J Respir Crit Care Med. 2025[...]